Global Bovine Lactoferrin Market is valued approximately at USD 421.23 million in 2023 and is anticipated to grow with a healthy growth rate of more than 7.80% over the forecast period 2024-2032. Bovine lactoferrin, a glycoprotein abundant in cow's milk and other mammalian secretions, such as human milk, serves as a cornerstone of the innate immune system. It operates as both a formidable antimicrobial warrior and a vital iron transporter. Its multifaceted nature extends to an array of biological functions, encompassing antibacterial, antiviral, antifungal, anti-inflammatory, and immunomodulatory capabilities. Also, the key trend of Bovine Lactoferrin market is growing demand for the functional and nutraceuticals foods. Consumers are increasingly seeking out functional foods and nutraceuticals that offer health benefits beyond basic nutrition. Bovine lactoferrin, with its diverse biological activities and potential health benefits, is being incorporated into various food and beverage products to meet this demand.
Growing awareness among consumers about the health benefits of bovine lactoferrin is driving its demand. Research studies highlighting its potential in boosting the immune system, promoting gut health, and aiding in the prevention of various diseases are contributing to the market expansion. Also, bovine lactoferrin is utilized in a wide range of applications in both nutraceuticals and pharmaceuticals. It is used in infant formula, dietary supplements, sports nutrition products, and pharmaceutical formulations. The versatility of bovine lactoferrin in these sectors is driving its market growth. Nevertheless, the anticipated market growth from 2024 to 2032 may encounter obstacles due to the elevated expenses associated with lactoferrin-infused products.
The key regions considered for the global Bovine Lactoferrin market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. In 2023, Asia Pacific was the largest regional market in terms of revenue. The regional market's prominence can be primarily attributed to the rising demand for infant formula and dietary supplements among the population. This surge in the demand is driving the integration of lactoferrin into infant formula and other nutritious food products to enhance their nutritional value. Additionally, a decline in breastfeeding rates is contributing to the increased demand for infant formula in the region. This, together with the increased usage of these products as additional nutritional sources to breast milk in infant formula, is collectively driving market growth.
Major market player included in this report are:
MILEI GmbH (Germany)
Bega Cheese Ltd. (Australia)
Fonterra Co-operative Group (New Zealand)
FrieslandCampina DOMO (Netherlands)
Beston Global Food Company Ltd (Australia)
SAVENCIA SA (France)
Saputo Dairy Australia Pty Ltd. (Australia)
Noumi Limited (Australia)
Synlait Ltd. (New Zealand)
Glanbia Plc. (Ireland)
The detailed segments and sub-segment of the market are explained below:
By Product
Freeze-dried
Spray-dried
By Application
Infant Formula
Dietary Supplements
Pharmaceuticals
Food
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Middle East & Africa
Saudi Arabia
South Africa
RoMEA
Years considered for the study are as follows:
Historical year - 2022
Base year - 2023
Forecast period - 2024 to 2032
Key Takeaways:
Market Estimates & Forecast for 10 years from 2022 to 2032.
Annualized revenues and regional level analysis for each market segment.
Detailed analysis of geographical landscape with Country level analysis of major regions.
Competitive landscape with information on major players in the market.
Analysis of key business strategies and recommendations on future market approach.
Analysis of competitive structure of the market.
Demand side and supply side analysis of the market